Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,598
Funds Holding Change
-86
Funds Holding Growth
-2%
Value
$1.38T
Holding in Top 10
679
Top 10 Change
-230
Top 10 Growth
-25%
Value Growth
-8%
New
196
Increased
2,371
Reduced
2,700
Closed
206
Capital Inflow
$44.4B
Capital Outflow
$40.7B
Net Capital Flow
+$3.65B
Capital Flow Change
-$11.4B
Calls
$21.5B
Puts
$18.7B
Net Calls
+$2.76B
Put/Call Ratio
0.87